发明名称 8-PIPERIDINIL-2-PRIDINIL-PIRIMIDO-[1,2-A]PIRIDIMIN-6-ONA SUBSTITUÍDA E DERIVADOS DA 8-PIPERIDINIL-2-PIRIMIDINIL-PIRIMIDO[1,2-A]PIRIMIDIN-6-ONA
摘要 The invention relates to a pyrimidone derivative represented by formula (I) or a salt thereof: wherein: X represents two hydrogen atoms, a sulfur atom, an oxygen atom or a C 1-2 alkyl group and a hydrogen atom; Y represents a bond, a carbonyl group or a methylene group optionally substituted; R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the ring being optionally substituted; R2 represents a benzene ring or a naphthalene ring; the rings being optionally substituted; R3 represents a hydrogen atom, a C 1-6 alkyl group or a halogen atom; R4 represents a hydrogen atom, a C 1-6 alkoxy carbonyl group or a C 1-6 alkyl group optionally substituted; n represents 0 to 3; p represents 2; q represents 0; o represents 0, 1 or 2 and m represents respectively 4, 3 or 2, o+m being equal to 4. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3², such as Alzheimer disease.
申请公布号 BRPI0718519(A2) 申请公布日期 2014.04.15
申请号 BR2007PI18519 申请日期 2007.11.06
申请人 SANOFI-AVENTIS;MITSUBISHI TANABE PHARMA CORPORATION 发明人 ALISTAIR LOCHEAD;MOURAD SAADY;FRANCK SLOWINSKI;PHILIPPE YAICHE
分类号 C07D487/04;A61K31/519;A61P25/28;A61P33/06;A61P35/00;A61P37/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址